clock menu more-arrow no yes

Filed under:

Know the Enemy Daily Links 11/10: Broncos and Chiefs both continue winning

Tom Szczerbowski

AFC West

Broncos

Broncos Raiders final score 41-17: Peyton Manning, C.J. Anderson throttle Raiders in Oakland - Mile High Report

Broncos 41, Raiders 17: In which C.J. Anderson burned his home state to the ground.

Demaryius Thomas surpasses 1,000 yards receiving just nine games into the season - Mile High Report

If there is any question that Demaryius Thomas is one of the NFL's premier wide receivers then just take a look at his career year in progress for 2014.

Chargers

Changes the Chargers need to make on both sides of the line of scrimmage - Bolts from the Blue

Kyle Posey reviews both of the Chargers' lines and identifies necessary changes.

What do the San Diego Chargers do best? - Bolts from the Blue

As the San Diego Chargers head into their bye week, what is their biggest strength and how can they build on it?

Chiefs

Chiefs-Bills final score: These plays helped Kansas City beat Buffalo, 17-13 - Arrowhead Pride

What a game for the Chiefs.

Remember that time Rodney Harrison said the Chiefs season was "done" after one week? - Arrowhead Pride

This is kind of funny to look at now.

NFL

NFL wants quick resolution on Adrian Peterson as NFLPA grievance looms - USA Today

The NFL says it is "moving as quickly as possible" to make a decision on potential discipline for Minnesota Vikings running back Adrian Peterson under the imminent threat of an expedited grievance requesting the 2012 NFL MVP's immediate reinstatement.

Medical marijuana company developing drug to protect NFL players’ brains - Fox News

"We've taken the preclinical approach so far to date on our first indication which is hepatic encephalopathy, which is a brain-liver disorder, where you do have neuronal degradation and degeneration, oxidative stress," Dean Petkanas, CEO of KannaLife Sciences told FoxNews.com. "So we felt that we could look at that in parallel with chronic traumatic encephalopathy, (CTE) another brain-related disease, and see if neuroprotection would indeed be afforded across that panel."